CYP21A1P and congenital adrenal hyperplasia: For example, in Taiwan’s newborn screening program, funded by the National Health Insurance, the pathogenic gene for congenital adrenal hyperplasia (CYP21A2) has a pseudogene, CYP21A1P, which increases the risk of diagnostic error.